• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ocular Therapeut (NQ: OCUL )

    4.740 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 28
    Open 4.740
    Bid (Size) 4.500 (1)
    Ask (Size) 5.190 (2)
    Prev. Close 4.740
    Today's Range 4.740 - 4.740
    52wk Range 1.995 - 11.31
    Shares Outstanding 148,627,439
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    2 Small-Cap Growth Stocks With Room To Run
    These two small-cap growth stocks could be ready to run. 
    Via The Motley Fool
    Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    -1.46%
    -1.46%
    1 Month
    -45.45%
    -45.45%
    3 Month
    -3.66%
    -3.66%
    6 Month
    +66.32%
    +66.32%
    1 Year
    -23.30%
    -23.30%

    More News

    Read More
    Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
    Via Benzinga
    Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
    Via Benzinga
    The 3 Best Biotech Stocks to Buy Now: Q2 Edition
    Via InvestorPlace
    Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
    Via InvestorPlace
    Million-Dollar Bets: 3 Under-$15 Stocks With Massive Potential
    Via InvestorPlace
    Decoding 6 Analyst Evaluations For Ocular Therapeutix
    Via Benzinga
    These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results
    Via Benzinga
    Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Ocular Therapeutix: Q4 Earnings Insights
    Via Benzinga
    Earnings Outlook For Ocular Therapeutix
    Via Benzinga
    Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Earnings Scheduled For March 11, 2024
    Via Benzinga
    $7M Bet On Ocular Therapeutix? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    Piper Sandler Maintains Overweight Rating for Ocular Therapeutix: Here's What You Need To Know
    Via Benzinga
    3 Stocks to Buy That Are Up 100% or More in 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.